{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:10:33Z","timestamp":1789564233903,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.yexmp.2026.105067","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:44:16Z","timestamp":1784295856000},"page":"105067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Automated imaging workflow for FISH-stained tissue microarrays enables assessment of FGFR2 translocations in a large intrahepatic cholangiocarcinoma patient cohort"],"prefix":"10.1016","volume":"147","author":[{"given":"Isis","family":"Lozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Schmoranzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Reutzel-Selke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Krenzien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor M.","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Pratschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzel","family":"Sch\u00f6ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.yexmp.2026.105067_bb0005","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","article-title":"Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105067_bb0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.32074\/1591-951X-859","article-title":"FGFR2 testing in cholangiocarcinoma: translating molecular studies into clinical practice","volume":"115","author":"Angerilli","year":"2023","journal-title":"Pathologica"},{"issue":"4","key":"10.1016\/j.yexmp.2026.105067_bb0015","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/hep.26890","article-title":"Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma","volume":"59","author":"Arai","year":"2014","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.yexmp.2026.105067_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.152662","article-title":"Analysis of NTRK expression in gastric and esophageal adenocarcinoma (AGE) with pan-TRK immunohistochemistry","volume":"215","author":"Arnold","year":"2019","journal-title":"Pathol. Res. Pract."},{"issue":"9","key":"10.1016\/j.yexmp.2026.105067_bb0025","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105067_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.yexmp.2026.105067_bb0035","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/14737159.2018.1522252","article-title":"Tissue microarrays - translational biomarker research in the fast lane","volume":"18","author":"Behling","year":"2018","journal-title":"Expert. Rev. Mol. Diagn."},{"issue":"5","key":"10.1016\/j.yexmp.2026.105067_bb0040","doi-asserted-by":"crossref","first-page":"541","DOI":"10.6004\/jnccn.2021.0022","article-title":"Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Benson","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"9","key":"10.1016\/j.yexmp.2026.105067_bb0045","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nrgastro.2011.131","article-title":"Clinical diagnosis and staging of cholangiocarcinoma","volume":"8","author":"Blechacz","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.yexmp.2026.105067_bb0050","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","article-title":"Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma","volume":"60","author":"Bridgewater","year":"2014","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105067_bb0055","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10735-006-9069-y","article-title":"Fluorescent in situ hybridization on tissue microarrays: challenges and solutions","volume":"38","author":"Brown","year":"2007","journal-title":"J. Mol. Histol."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105067_bb0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00535-024-02175-y","article-title":"FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma","volume":"60","author":"Cao","year":"2025","journal-title":"J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105067_bb0065","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/cjp2.64","article-title":"Fluorescence in situ hybridization in surgical pathology: principles and applications","volume":"3","author":"Cheng","year":"2017","journal-title":"J. Pathol. Clin. Res."},{"issue":"12","key":"10.1016\/j.yexmp.2026.105067_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115383","article-title":"Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications","volume":"9","author":"Churi","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.yexmp.2026.105067_bb0075","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jhep.2023.03.010","article-title":"EASL-ILCA clinical practice guidelines on the management of intrahepatic cholangiocarcinoma","volume":"79","year":"2023","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.yexmp.2026.105067_bb0080","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2206834","article-title":"Futibatinib for FGFR2-rearranged intrahepatic cholangiocarcinoma","volume":"388","author":"Goyal","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.yexmp.2026.105067_bb0085","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s00292-020-00831-7","article-title":"Application of FISH in the diagnosis of lung cancer","volume":"41","author":"Hieggelke","year":"2020","journal-title":"Pathologe"},{"key":"10.1016\/j.yexmp.2026.105067_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00080","article-title":"Cholangiocarcinoma with FGFR genetic aberrations: a unique clinical phenotype","volume":"2","author":"Jain","year":"2018","journal-title":"JCO Precis. Oncol."},{"issue":"7","key":"10.1016\/j.yexmp.2026.105067_bb0095","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/hmg\/10.7.657","article-title":"Tissue microarray technology for high-throughput molecular profiling of cancer","volume":"10","author":"Kallioniemi","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexmp.2026.105067_bb0100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cytogfr.2019.12.005","article-title":"Functions of FGFR2 corrupted by translocations in intrahepatic cholangiocarcinoma","volume":"52","author":"Li","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"17","key":"10.1016\/j.yexmp.2026.105067_bb0105","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-18-0078","article-title":"Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: potential targets for intervention","volume":"24","author":"Lowery","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105067_bb0110","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2406052","article-title":"Clinical prognosticators and targets in the immune microenvironment of intrahepatic cholangiocarcinoma","volume":"13","author":"Lozzi","year":"2024","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.yexmp.2026.105067_bb0115","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00535-020-01735-2","article-title":"Molecular detection and clinicopathological characteristics of advanced\/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE study)","volume":"56","author":"Maruki","year":"2021","journal-title":"J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.yexmp.2026.105067_bb0120","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.annonc.2020.07.014","article-title":"Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO precision medicine working group","volume":"31","author":"Mosele","year":"2020","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.yexmp.2026.105067_bb0125","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.yexmp.2026.105067_bb0130","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41416-022-01908-1","article-title":"Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing","volume":"127","author":"Neumann","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"9","key":"10.1016\/j.yexmp.2026.105067_bb0135","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1111\/liv.15984","article-title":"Prognostic value of FGFR2 alterations in patients with iCCA undergoing surgery or systemic treatments: a meta-analysis","volume":"44","author":"Niu","year":"2024","journal-title":"Liver Int."},{"issue":"29","key":"10.1016\/j.yexmp.2026.105067_bb0140","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1200\/JCO.2016.66.6693","article-title":"HER2 gene amplification testing by fluorescent in situ hybridization (FISH): comparison of the ASCO-college of American pathologists guidelines with FISH scores used for enrollment in breast cancer international research group clinical trials","volume":"34","author":"Press","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.yexmp.2026.105067_bb0145","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41419-021-03548-4","article-title":"Typing FGFR2 translocation determines the response to targeted therapy of intrahepatic cholangiocarcinomas","volume":"12","author":"Pu","year":"2021","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.yexmp.2026.105067_bb0150","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1055\/s-0044-1790230","article-title":"Expert consensus on the diagnosis and treatment of FGFR gene-altered solid tumors","volume":"11","author":"Xu","year":"2024","journal-title":"Glob. Med. Genet."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105067_bb0155","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/pin.13293","article-title":"Ewing and Ewing-like sarcomas: a morphological guide through genetically-defined entities","volume":"73","author":"Yoshida","year":"2023","journal-title":"Pathol. Int."},{"issue":"5","key":"10.1016\/j.yexmp.2026.105067_bb0160","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00428-025-04067-9","article-title":"FGFR2 fusion\/rearrangement analysis in intrahepatic cholangiocarcinoma using DNA\/RNA-based NGS and FISH","volume":"487","author":"Zhang","year":"2025","journal-title":"Virchows Arch."},{"issue":"6","key":"10.1016\/j.yexmp.2026.105067_bb0165","first-page":"1355","article-title":"Molecular detection of FGFR2 rearrangements in resected intrahepatic cholangiocarcinomas: FISH could be an ideal method in patients with histological small duct subtype","volume":"11","author":"Zou","year":"2023","journal-title":"J. Clin. Transl. Hepatol."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480026000468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480026000468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:54:26Z","timestamp":1789563266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480026000468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":33,"alternative-id":["S0014480026000468"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2026.105067","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Automated imaging workflow for FISH-stained tissue microarrays enables assessment of FGFR2 translocations in a large intrahepatic cholangiocarcinoma patient cohort","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2026.105067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105067"}}